Premium
Identification and in vitro characterisation of Lactobacillus plantarum strains from artisanal Bulgarian white brined cheeses
Author(s) -
Georgieva Ralitsa N.,
Iliev Ilia N.,
Chipeva Valentina A.,
Dimitonova Silvia P.,
Samelis John,
Danova Svetla T.
Publication year - 2008
Publication title -
journal of basic microbiology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.58
H-Index - 54
eISSN - 1521-4028
pISSN - 0233-111X
DOI - 10.1002/jobm.200700355
Subject(s) - lactobacillus plantarum , microbiology and biotechnology , ampicillin , nalidixic acid , penicillin , tetracycline , ciprofloxacin , probiotic , biology , antibiotics , chemistry , bacteria , food science , lactic acid , genetics
Lactobacillus plantarum strains were isolated from fully ripened, white brined Bulgarian home‐made cheeses. Strains were derived from phenotypically homogenous Lactobacillus group and were identified as L. plantarum based on both phenotypic and molecular identification (species‐specific and multiplex PCR) methods. Heterogeneity of L. plantarum isolates was evaluated by Rep‐PCR analysis. Further antimicrobial activity, antibiotic susceptibility and transit tolerance of the strains were evaluated. Most of them showed broad spectrum of activity against Gram‐negative bacteria (including human pathogens) independent on the presence of organic acids or hydrogen peroxide. All strains were sensitive to amoxicillin and sulfamethoxazole/trimethoprim, resistant to clinically relevant β ‐lactame antibiotics (penicillin and ampicillin) and to nalidixic acid, ciprofloxacin, streptomycin, and vancomycin. Significant variability in the sensitivity to tetracycline was noted. The tolerance to low pH, bile salts, pepsin and pancreatin at concentrations similar to those in the gastrointestinal tract was strain‐dependent. The exposure to bile salts was less destructive than exposure to pH 2.0 for all tested strains. Based on their combined responses to the above selection criteria, four L. plantarum strains, RL29, RL34, RL36 and RL37, were selected as potential probiotics for in vivo studies. (© 2008 WILEY‐VCH Verlag GmbH & Co. KGaA, Weinheim)